Related Experiment Videos
Fetal magnetocardiography: the clinician's viewpoint
1Department of Pediatric Cardiology, University Hospital of Cologne, Germany.
Neurology & Clinical Neurophysiology : NCN
|July 14, 2005
Summary
Fetal magnetocardiogram (FMCG) provides reliable cardiac electrical activity recordings from 15 weeks gestation. Standardized techniques enable reproducible measurements for clinical applications, especially for high-risk pregnancies.
Area of Science:
- Biomedical Engineering
- Cardiology
- Fetal Medicine
Background:
- Fetal magnetocardiogram (FMCG) records the heart's electrical activity.
- Recordings are feasible from approximately 15 weeks of gestation.
- FMCG offers accurate cardiac time interval measurements.
Purpose of the Study:
- To highlight the clinical utility of fetal magnetocardiogram.
- To emphasize the importance of standardization in FMCG.
- To establish normal values for different gestational ages.
Main Methods:
- Reliable recording of FMCG from 15 weeks gestation.
- Accurate measurement of cardiac time intervals.
- Real-time reflection of fetal cardiac electrical activity.
Main Results:
- Standardized recording, processing, and measurement yield reproducible data.
- Established normal values enhance clinical applicability.
- FMCG is particularly useful for high-risk pregnancies.
Conclusions:
- Standardized FMCG is clinically applicable.
- Reproducible data supports widespread use.
- FMCG aids in managing fetuses at risk of arrhythmias.